Characteristics And Skin Cancer Risk Of Psoriasis Patients With A History Of Skin Cancer In Badbir

K.J. Mason,A.D. Burden,J.N.W.N. Barker,M. Lunt,H. Ali,C.E. Kleyn,K. McElhone,M.M. Soliman,A.C. Green,C.E.M. Griffiths,N.J. Reynolds, A.D. Ormerod,Fiona Browne,Ian Evans,Brian Kirby, Linda Lawson,Philip Laws, Teena Mackenzie,Tess McPherson,Ruth Murphy,Caroline Owen, Eleanor Pearson, Josh Richards,Catherine Smith,Richard Warren, Gabrielle Belcher,Anthony Bewley,Simon Morrison

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY（2021）

引用 2|浏览6

暂无评分

摘要

A cohort study of patients with moderate-severe psoriasis registered to the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) determined that there was no association between developing a first basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) following treatment with biologic therapy when compared to non-biologic systemic therapies.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要